This public procurement record has 4 releases in its history.

Award

07 Feb 2024 at 08:54

Award

07 Feb 2024 at 08:54

Award

07 Feb 2024 at 08:54

Tender

20 Oct 2023 at 14:00

Summary of the contracting process

The NHS National Services Scotland has completed the procurement process for the supply of pharmaceutical products. This includes the procurement of NP47923a Adalimumab, NP47923b Tocilizumab, and NP47923c Eculizumab. The framework agreement has been awarded to multiple suppliers under an unranked multi-supplier framework model. The total contract value is £92,000,000. The procurement method used was an open procedure. The main procurement category is goods, and the contracting authority can be reached at Gyle Square, Edinburgh, UK.

This public tender presents significant business growth opportunities for suppliers of pharmaceutical products willing to engage with NHS Scotland. The procurement process is at an active stage with a contract value of £92 million spread across different product lines. Suppliers with expertise in pharmaceuticals and a track record of meeting quality requirements would be well-suited to compete in this competitive procurement environment. Interested businesses should ensure compliance with technical and suitability criteria outlined in the tender documentation to enhance their chances of successful participation and contract award.

How relevant is this notice?

Notice Title

NP47923b Tocilizumab

Notice Description

Supply of tocilizumab to NHS Scotland.

Lot Information

NP47923c Eculizumab

Supply of eculizumab vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 24 months, with an expiry date of 28 February 2026. This Lot has the option to extend by any number of periods, up to the maximum 24 months. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

NP47923b Tocilizumab

Supply of tocilizumab pre-filled pens/devices, pre-filled syringes and vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 12 months, with an expiry date of 28 February 2025. This Lot has the option to extend by any number of periods, up to the maximum 36 months. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty-six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

NP47923a Adalimumab

Supply of tocilizumab pre-filled pens/devices, pre-filled syringes and vials to NHS Scotland. The Authority has awarded this framework as an unranked multi-supplier framework per product line to two (2) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-040dc3
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/003972-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£92,000,000 £10M-£100M
Lots Value
£94,015,132 £10M-£100M
Awards Value
Not specified
Contracts Value
£83,673,821 £10M-£100M

Notice Dates

Publication Date
7 Feb 20242 years ago
Submission Deadline
21 Nov 2023Expired
Future Notice Date
Not specified
Award Date
11 Jan 20242 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Active, Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
9
Supplier Names

AbbVie Ltd

Alexion Rare Disease part of Astra Zeneca

Amgen Ltd

Biogen Idec Ltd

Celltrion Healthcare United Kingdom Limited

Fresenius Kabi Limited

Roche Products Ltd

Samsung Bioepis

Sandoz

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...